Guggenheim Maintains Buy on CG Oncology, Raises Price Target to $120

Benzinga · 1d ago
Guggenheim analyst Michael Schmidt maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $89 to $120.